Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies
Open Access
- 1 October 2004
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 45 (10) , 1859-1867
- https://doi.org/10.1194/jlr.m400095-jlr200
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The role of immune and inflammatory processes in the development of macrovascular disease in diabetesFrontiers in Bioscience-Landmark, 2003
- Inflammation in atherosclerosisNature, 2002
- Immunochemical Characterization of Purified Human Oxidized Low-Density Lipoprotein AntibodiesClinical Immunology, 2000
- Immunochemical approaches to AGE-structures: characterization of anti-AGE antibodiesJournal of Immunological Methods, 1998
- Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoproteinBiochemical Journal, 1997
- Isolation and Characterization of Human Antioxidized LDL AutoantibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Low density lipoprotein undergoes oxidative modification in vivo.Proceedings of the National Academy of Sciences, 1989